SCHEMBL18540342

SCHEMBL18540342

N#Cc1ccc(-c2cccc(-c3cc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)cc(-n4c5ccccc5c5ccccc54)c3)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.45
KDM4E B2RXH2 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
PGR P06401 2/20 0.38
PTGER4 P35408 2/20 0.37
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
TSPO P30536 1/20 0.36
KAT6A Q92794 1/20 0.36
RORC P51449 4/20 0.35
FAAH O00519 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HSP90AA1 P07900 1/20 0.35
PKM P14618 1/20 0.35
HTT P42858 1/20 0.35
MGLL Q99685 1/20 0.35
MYC P01106 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15248254 0.99 KDM4E (0.46) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL18540346 0.98 ATM (0.43) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL18540344 0.98 ATM (0.43) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL18540326 0.97 ATM (0.47) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL15250624 0.97 ATM (0.47) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL16942364 0.96 ATM (0.44) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL19276354 0.96 ATM (0.41) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL15248233 0.96 KDM4E (0.49) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL21984681 0.95 ATM (0.45) ATMKDM4EL3MBTL1PGRPTGER4
SCHEMBL18540331 0.95 KDM4E (0.45) ATMKDM4EL3MBTL1PGRPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10193082-B2 Condensed-cyclic compound and organic light emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-01-29 US disclosed
US-20170054082-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-02-23 US disclosed
US-20170054082-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10193082-B2 Condensed-cyclic compound and organic light emitting device including the same CRY1, CNOT9, CNOT1 ATM 1306/4885KDM4E 3311/4885L3MBTL1 494/4885
US-20170054082-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME CRY1, CNOT9, CNOT1 ATM 1306/4885KDM4E 3311/4885L3MBTL1 494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.